| Evidence of the transient nature of the Th17 phenotype of CD4+ CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis L Cosmi, R Cimaz, L Maggi, V Santarlasci, M Capone, F Borriello, ... Arthritis & Rheumatism 63 (8), 2504-2515, 2011 | 247 | 2011 |
| Prevention of flare recurrences in childhood‐refractory chronic uveitis: an open‐label comparative study of adalimumab versus infliximab G Simonini, A Taddio, M Cattalini, R Caputo, C De Libero, S Naviglio, ... Arthritis care & research 63 (4), 612-618, 2011 | 244 | 2011 |
| Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative T Constantin, I Foeldvari, J Anton, J De Boer, S Czitrom-Guillaume, ... Annals of the rheumatic diseases 77 (8), 1107-1117, 2018 | 222 | 2018 |
| Differentiating PFAPA syndrome from monogenic periodic fevers M Gattorno, R Caorsi, A Meini, M Cattalini, S Federici, F Zulian, E Cortis, ... Pediatrics 124 (4), e721-e728, 2009 | 212 | 2009 |
| Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry ME Zannin, C Birolo, VM Gerloni, E Miserocchi, I Pontikaki, MP Paroli, ... The Journal of rheumatology 40 (1), 74-79, 2013 | 201 | 2013 |
| Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment … N Ruperto, DJ Lovell, R Cuttica, P Woo, S Meiorin, C Wouters, ... Annals of the Rheumatic Diseases 69 (4), 718-722, 2010 | 175 | 2010 |
| Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis S Stagi, T Giani, G Simonini, F Falcini Rheumatology 44 (4), 517-520, 2005 | 157 | 2005 |
| Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis T Avčin, R Cimaz, F Falcini, F Zulian, G Martini, G Simonini, ... Annals of the rheumatic diseases 61 (7), 608-611, 2002 | 157 | 2002 |
| Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach G Simonini, P Paudyal, GT Jones, R Cimaz, GJ Macfarlane Rheumatology 52 (5), 825-831, 2013 | 156 | 2013 |
| Clinical and transcriptional response to the long‐acting interleukin‐1 blocker canakinumab in Blau syndrome–related uveitis G Simonini, Z Xu, R Caputo, C De Libero, I Pagnini, V Pascual, R Cimaz Arthritis & Rheumatism 65 (2), 513-518, 2013 | 152 | 2013 |
| Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit S Trapani, F Grisolia, G Simonini, GB Calabri, F Falcini Seminars in arthritis and rheumatism 29 (6), 348-359, 2000 | 152 | 2000 |
| Anakinra treatment in drug-resistant Behcet’s disease: a case series L Cantarini, A Vitale, P Scalini, CA Dinarello, D Rigante, R Franceschini, ... Clinical Rheumatology 34, 1293-1301, 2015 | 147 | 2015 |
| Current Evidence of Anti–Tumor Necrosis Factor α Treatment Efficacy in Childhood Chronic Uveitis: A Systematic Review and Meta‐Analysis Approach of Individual Drugs G Simonini, K Druce, R Cimaz, GJ Macfarlane, GT Jones Arthritis care & research 66 (7), 1073-1084, 2014 | 139 | 2014 |
| Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives L Cantarini, OM Lucherini, I Muscari, B Frediani, M Galeazzi, MG Brizi, ... Autoimmunity reviews 12 (1), 38-43, 2012 | 127 | 2012 |
| Early predictors of juvenile sacroiliitis in enthesitis-related arthritis I Pagnini, S Savelli, M Matucci-Cerinic, C Fonda, R Cimaz, G Simonini The Journal of rheumatology 37 (11), 2395-2401, 2010 | 126 | 2010 |
| Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in … G Simonini, A Taddio, M Cattalini, R Caputo, C de Libero, F Parentin, ... Pediatric Rheumatology 11, 1-7, 2013 | 118 | 2013 |
| Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis S Gabriele, P Alberto, G Sergio, F Fernanda, MC Marco Toxicology 155 (1-3), 1-15, 2000 | 117 | 2000 |
| Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status F Galluzzi, S Stagi, R Salti, S Toni, E Piscitelli, G Simonini, F Falcini, ... European Journal of Endocrinology 153 (6), 879-885, 2005 | 114 | 2005 |
| Current therapeutic approaches to autoimmune chronic uveitis in children G Simonini, L Cantarini, C Bresci, M Lorusso, M Galeazzi, R Cimaz Autoimmunity reviews 9 (10), 674-683, 2010 | 109 | 2010 |
| Pediatric rheumatology-Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis S Nielsen, N Ruperto, V Gerloni, G Simonini, E Cortis, L Lepore, ... Clinical & Experimental Rheumatology 26 (4), 688, 2008 | 104 | 2008 |
